Status:

COMPLETED

Efficacy & Safety Study of Recombinant Human Erythropoietin -Alpha, in Patients With Anemia of Chronic Renal Failure

Lead Sponsor:

Cadila Pharnmaceuticals

Conditions:

Anemia

Eligibility:

All Genders

18-70 years

Phase:

PHASE3

Brief Summary

To establish the efficacy and Safety of rHu-EPO-alpha in patients with anemia of Chronic Renal Failure.

Detailed Description

Despite impressive advances in the safety of the blood supply, the search for therapeutic alternatives to blood continues. Recombinant Human Erythropoietin (rHu-EPO), along with iron, vitamin B12, and...

Eligibility Criteria

Inclusion

  • Patients between 18 to 70 yrs of age of either sex.
  • CRF patients who are EPO naïve or have been off EPO or similar Erythropoietic drugs for more than 4 weeks, falling with-in CKD stage III to V.
  • Patients who are willing to give the consent
  • Patient with Anemia of Chronic Renal Failure with Hb \< 10.

Exclusion

  • Patients who are known hypersensitive to rHu-EPO.
  • Patient's with history of anemia due to causes other than anemia of CRF.
  • Patient's with history of Active infections, Hemoglobinopathies, Neoplastic diseases, and HIV infection.
  • Patient's with history of G.I. bleeding (Overt or Occult).
  • Patient's with history of serious or unstable medical or psychological conditions that could compromise the patient's safety or successful trial participation.
  • Patients with abnormal liver function test. However, patients with HBsAg and HCV positive shall be included provided their Transaminases are normal.
  • Female patient's of child bearing potential and not having undergone permanent sterilization procedures. Pregnant and lactating female patients.
  • Patients unwilling or unable to comply with the study procedures. Chronic alcoholic or drug abuse patients

Key Trial Info

Start Date :

December 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2007

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT00399269

Start Date

December 1 2006

End Date

June 1 2007

Last Update

June 11 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Dr. Shishir Gang

Nadiād, Gujarat, India